[JPI Seminar] Ministry of Health, Labour and Welfare "Overview and Recent Trends of the Act on Securing Safety of Regenerative Medicine" Held on May 21 (Thu)

Key facts

  • [JPI Seminar] Ministry of Health, Labour and Welfare "Overview and Recent Trends of the Act on Securing Safety of Regenerative Medicine" Held on May 21 (Thu)
  • JPI (Japan Planning Institute) will host a seminar on May 21, 2026, featuring Takahiko Nagai from the Ministry of Health, Labour and Welfare. The seminar will provide a detailed overview and discuss recent trends of the Act on Securing Safety of Regenerative Medicine, focusing on its key points and practical considerations for rapid and safe provision of regenerative medicine.
  • Source: PR Times
  • Date: April 30, 2026

Direct answer

JPI (Japan Planning Institute) will host a seminar on May 21, 2026, featuring Takahiko Nagai from the Ministry of Health, Labour and Welfare. The seminar will provide a detailed overview and discuss recent trends of the Act on Securing Safety of Regenerative Medicine, focusing on its key points and practical considerations for rapid and safe provision of regenerative medicine.

Citation
[JPI Seminar] Ministry of Health, Labour and Welfare "Overview and Recent Trends of the Act on Securing Safety of Regenerative Medicine" Held on May 21 (Thu) (April 30, 2026), PR Times
Source
PR Times
Date
April 30, 2026
JPI (Japan Planning Institute) will host a seminar on May 21, 2026, featuring Takahiko Nagai from the Ministry of Health, Labour and Welfare. The seminar will provide a detailed overview and discuss recent trends of the Act on Securing Safety of Regenerative Medicine, focusing on its key points and practical considerations for rapid and safe provision of regenerative medicine.
イベントNQ 36/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 30, 2026 at 23:10
  • 🔍 Collected: April 30, 2026 at 14:31
  • 🤖 AI Analyzed: April 30, 2026 at 16:32 (2h 0m after Collected)
JPI (Japan Planning Institute) will host a seminar featuring Mr. Takahiko Nagai, Assistant Director of the Regenerative Medicine Research Promotion Office, Research and Development Policy Division, Medical Affairs Bureau, Ministry of Health, Labour and Welfare. He will provide a detailed explanation of the overview and recent trends of the Act on Securing Safety of Regenerative Medicine.

[Details and Application here] https://www.jpi.co.jp/seminar/17762

[Title]

In-depth explanation of key points and practical considerations based on the latest trends

Ministry of Health, Labour and Welfare: Overview and Recent Trends of the Act on Securing Safety of Regenerative Medicine

[Date and Time]

Thursday, May 21, 2026, 09:30 - 11:30

*Applications for archive distribution are also accepted after the seminar concludes.

[Lecturer]

Ministry of Health, Labour and Welfare

Medical Affairs Bureau, Research and Development Policy Division, Regenerative Medicine Research Promotion Office

Assistant Director

Mr. Takahiko Nagai

[Lecture Overview]

The "Act on Securing Safety of Regenerative Medicine, etc." (hereinafter referred to as "this Act") was established in 2013 and enforced the following year, aiming to promote the rapid and safe provision and dissemination of regenerative medicine.

This Act stipulates matters that medical institutions must comply with when providing regenerative medicine, and systems related to the manufacturing of specific cell-processed products used in regenerative medicine. In Japan, clinical research involving regenerative medicine, cell therapy, and gene therapy, etc., falls under the scope of this Act.

This lecture will explain the overview of this Act, amendments, and recent trends related to the Act.

[Lecture Topics]

1. Overview of the Act on Securing Safety of Regenerative Medicine
2. Medical technologies subject to the Act on Securing Safety of Regenerative Medicine and risk classification
3. Matters concerning regenerative medicine provision standards and regenerative medicine provision plans
4. Matters concerning certified regenerative medicine committees
5. Matters concerning facilities manufacturing specific cell-processed products, etc.
6. Provisions of the supplementary rules of the amended Act
7. Guidance on procedures based on the Act on Securing Safety of Regenerative Medicine
8. Related Q&A
9. Business card exchange and networking session

In addition to direct dialogue and Q&A with lecturers who are usually difficult to meet, this is a valuable opportunity unique to JPI seminars, where participants can gain practical information and new collaboration opportunities through networking with participants from various industries.

[Attendance Format]

● On-site attendance (archive distribution not included)

● Live streaming attendance (archive distribution not included)

● Archive distribution attendance

*Attendees of on-site and live streaming can add archive distribution for a special price of 18,500 yen (tax included).

[Tuition Fee]

1 person: 37,430 yen (tax included)

Benefit: For every 1 attendee, 1 companion from the same corporation can attend for free (registration required).

*For those belonging to local public organizations, up to 2 people can attend for 11,000 yen (tax included / on-site and live streaming only, same attendance format).

[Details and Application here] https://www.jpi.co.jp/seminar/17762

◆We also arrange questions and introductions to lecturers after the seminar.

◆It is highly utilized for building human networks among lecturers and participants, and for creating new businesses.

◆Applications for archive distribution are also accepted after the seminar concludes.

[Contact]

Japan Planning Institute Co., Ltd.

Kowa Hiroo Building, 5-2-32 Minami Azabu, Minato-ku, Tokyo 106-0047

TEL.03-5793-9761 FAX.03-5793-9767

URL https://www.jpi.co.jp

[About JPI (Japan Planning Institute)]

For half a century, JPI has been providing valuable information in the form of limited-attendance real seminars for executives and senior managers aiming to foster national knowledge, supporting the spread of national policies and projects as a "bridge of knowledge" between government, bureaucracy, and the private sector.

FAQ

What are the key facts in this article?

JPI (Japan Planning Institute) will host a seminar on May 21, 2026, featuring Takahiko Nagai from the Ministry of Health, Labour and Welfare. The seminar will provide a detailed overview and discuss recent trends of the Act on Securing Safety of Regenerative Medicine, focusing on its key points and practical considerations for rapid and safe provision of regenerative medicine.

What is the direct answer?

JPI (Japan Planning Institute) will host a seminar on May 21, 2026, featuring Takahiko Nagai from the Ministry of Health, Labour and Welfare. The seminar will provide a detailed overview and discuss recent trends of the Act on Securing Safety of Regenerative Medicine, focusing on its key points and practical considerations for rapid and safe provision of regenerative medicine.

What is the source and date?

PR Times: https://prtimes.jp/main/html/rd/p/000001743.000042328.html | April 30, 2026